CoChat

Remimazolam: A Review in Procedural Sedation

Lee, Arnold, Shirley, Matt · 2021 · Drugs

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Remimazolam (Byfavo™) is a benzodiazepine sedative that is indicated for the induction and maintenance of procedural sedation in adults. Remimazolam was efficacious in three phase III trials in patients requiring endoscopies. Significantly higher procedure success rates (composite of the completion of the procedure, top-up doses of study drug within predefined limits and no requirement for rescue therapy) were observed with remimazolam than with placebo, with the majority of placebo recipients requiring rescue midazolam. Furthermore, remimazolam significantly reduced times to onset of sedation and recovery in comparison with placebo (plus rescue). Remimazolam is generally well tolerated, with hypotension and hypertension the most common adverse drug reactions. Higher doses of concomitant fentanyl with remimazolam may increase the incidence of adverse drug reactions and deep sedation events. However, no correlation was observed between depth of sedation and vital signs. In summary, remimazolam is a useful option for the induction and maintenance of procedural sedation. Although pharmacoeconomic analyses for remimazolam are not yet available, the rapid induction of sedation and short recovery times with remimazolam may be beneficial in improving patient throughput in clinics.

Overview

Integrity signals

Registry

Crossref · 10.1007/s40265-021-01544-8

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Research works printed but not linked: 2

  1. Benzoni T, Cascella M. Procedural sedation. StatPearls. Treasure Island (FL); 2020. https://www.ncbi.nlm.nih.gov/. Accessed 21 May 2021.
  2. Schekenbach V, Hofmann P, Drexler B. Remimazolam: the future of TIVA? [German]. Anästh Intensivmed. 2021;62(3):111–7.

Cited by

See all 194

Metadata

Authors
Lee, A., & Shirley, M.
Affiliations
Springer Nature (New Zealand) (NZ)
Corresponding author
Lee, Arnold
Venue
Drugs
Published
2021-07
Volume
81
Issue
10
Pages
1193-1201
ISSN
  • 0012-6667 (ISSN-L)
  • 1179-1950
OpenAlex
W3177162180
Cited by
194
References
20
Citations by year
2026: 33 · 2025: 54 · 2024: 58 · 2023: 33 · 2022: 15 · 2021: 1
FWCI
30.64
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
  • Health Sciences › Veterinary › Small Animals › Veterinary Pharmacology and Anesthesia
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
Keywords
remimazolam, procedural sedation, endoscopic sedation, adverse drug reactions, sedation depth, patient throughput, pharmacokinetics, pharmacodynamics, drug interactions, pharmacoeconomics, drug safety and efficacy
MeSH terms
Anesthesia, Anesthesia Recovery Period, Benzodiazepines, Dose-Response Relationship, Drug, Endoscopy, Humans, Hypnotics and Sedatives, Clinical Trials, Phase III as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.